What can real-world data teach us about treating patients with unresectable hepatocellular carcinoma? [0.03%]
真实世界数据能教给我们什么关于治疗不可切除的肝细胞癌患者的知识？
A Dalbeni,F Cattazzo,L A Natola et al.
A Dalbeni et al.
Introduction: Hepatocellular carcinoma(HCC) remains a major global health concern, as the most common primary livercancer and the fourth leading cause of cancer-related mortality. ...
Bridgette B McNally,Elizabeth J Carey
Bridgette B McNally
Introduction: Cholestatic liver disease encompasses a broad group of disorders related to impaired normal bile formation, secretion or excretion. These diseases present with symptoms of fatigue, jaundice and pruritus and ...
Arterial stiffness as a complication of metabolic dysfunction-associated steatotic liver disease: a systematic review and meta-analysis [0.03%]
动脉僵硬度作为与代谢功能障碍相关脂肪性肝病的并发症：系统评价和荟萃分析
Alexios Giannakodimos,Evangelos Oikonomou,Panteleimon Pantelidis et al.
Alexios Giannakodimos et al.
Introduction: The purpose of this systematic review and meta-analysis is to investigate the association of metabolic dysfunction-associated steatotic liver disease (MASLD) with arterial stiffness and enlighten on potentia...
Natasha K Klemm,Joseph D Feuerstein
Natasha K Klemm
Introduction: Stricturing Crohn's disease is a common phenotype and treatment aims to improve symptoms, prevent complications, assess for proximal bowel disease activity and screen for upstream neoplasm. Management is cha...
The reliability of freely accessible, baseline, general-purpose large language model generated patient information for frequently asked questions on liver disease: a preliminary cross-sectional study [0.03%]
自由访问的基础通用大型语言模型生成的肝病常见问题患者信息的可靠性：初步横断面研究
Madunil A Niriella,Pathum Premaratna,Mananjala Senanayake et al.
Madunil A Niriella et al.
Background: We assessed the use of large language models (LLMs) like ChatGPT-3.5 and Gemini against human experts as sources of patient information. Resea...
Endoscopic ultrasound guided liver biopsy and portal pressure gradient: when, why and how? Can it become the standard of care in endo-hepatology? [0.03%]
内镜超声引导肝穿刺和门脉压力梯度检测：何时进行，为何进行以及如何进行？其能否成为内镜肝脏病学的常规标准？
Jahnvi Dhar,Amit Yadav,Suvradeep Mitra et al.
Jahnvi Dhar et al.
Introduction: The armamentarium of 'Endo-hepatology' is proliferating with the advancements in techniques and availability of new devices in the field of endoscopic ultrasound (EUS). This has resulted in the merger of mul...
Progressing advanced therapies for inflammatory bowel disease: Current status including dual biologic therapy and discontinuation of biologics [0.03%]
推进炎症性肠病的先进疗法：现状包括双重生物制剂疗法和停用生物制剂
Kazuo Yashima,Hiroki Kurumi,Naoyuki Yamaguchi et al.
Kazuo Yashima et al.
Introduction: Advanced therapies (ADT) that encompass biological agents and small molecules have been approved for the treatment of inflammatory bowel disease (IBD), broadening the spectrum of available treatment options....
Comprehensive management of gastrointestinal fistulas in necrotizing pancreatitis: a review of diagnostic and therapeutic approaches [0.03%]
坏死性胰腺炎并发胃肠瘘的综合管理：诊断和治疗方式的综述
Dujiang Yang,Lingrui Yue,Bowen Tan et al.
Dujiang Yang et al.
Introduction: Gastrointestinal fistula (GIF) is a rare but severe complication in patients with necrotizing pancreatitis (NP), significantly prolonging disease course and increasing morbidity and mortality. Its subtle and...
The role of immunogenicity in optimizing biological therapies for inflammatory bowel disease [0.03%]
免疫原性在优化炎症性肠病生物治疗中的作用
Konika Sharma,Bruno deSilva,Stephen B Hanauer
Konika Sharma
Introduction: Immunogenicity of biologic agents for inflammatory bowel disease (IBD) is a critical issue, especially for tumor necrosis factor (TNF) inhibitors, where anti-drug antibodies (ADAs) significantly impact drug ...
Unraveling the link: diagnosing metabolic dysfunction-associated steatotic liver disease in the context of decompensated cirrhosis [0.03%]
解开联系的谜团：在失代偿性肝硬化的背景下诊断与代谢功能障碍相关的脂肪性肝病
Mohamed El-Kassas,Marwa Khalaf Hassan,Khalid Al-Naamani
Mohamed El-Kassas